We bring together news, announcements and other updates from around Global Fund in this section. You can receive a notification every time a new update is published by using our really simple syndication (RSS) feed. See our RSS Feeds page for more information.
-
The Global Fund is very pleased to announce the appointment of John Grove as its new Chief Evaluation and Learning Officer, starting on 1 October 2022.
-
-
The Global Fund is pleased to announce the appointment of Susanne Kuehn as the new Ethics Officer and Head of the Ethics Office.
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria has been included in the ‘Good’ category in a leading international aid transparency index published today.
-
-
The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an expression of interest to have their products evaluated by the Expert Review Panel for Diagnostics.
-
20 May 2022
External Quality Assessment: Highest Possible Results for OIG Audit and Investigation Units
-
The following products have been recommended for use by the Expert Review Panel (ERP): Rifapentine 300mg tablets Al/Al strip pack manufactured by Lupin, India; Rifapentine/Isoniazid 300/300mg Al/Al strip pack manufactured by Lupin, India
-
03 May 2022
Global Fund Appoints Susie Rhee as General Counsel and Head of the Legal & Governance Department
The Global Fund is pleased to announce the appointment of Susie Rhee as the new General Counsel and Head of the Legal & Governance Department. -
08 April 2022
Opportunity for Evaluation of Diagnostic Products
The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an Expression of Interest (EoI) to have their products evaluated by the Expert Review Panel for Diagnostics (ERPD). This evaluation will focus particularly on dia...